![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
I De Waziers, M Garlatti, J Bouguet, PH Beaune and R Barouki
INSERM U75, CHU-Necker, Universite Rene Descartes, Paris, France.
Cytochromes P450 (P450s) are inducible drug-metabolizing enzymes involved in the metabolism of numerous endogenous and exogenous substrates. The regulation of some of these enzymes during experimental diabetes has been reported, but the direct involvement of insulin and the mechanism of its action remain unclear. The aim of our work was to study the effects of insulin on P450 2B and 2E expression in differentiated Fao hepatoma cells. Exposure of the cells to 0.1 microM insulin caused 60% and 80% decreases in the steady state levels of P450 2B and 2E proteins, respectively, within 24 hr. Before this, a rapid decrease in the corresponding messages was observed. Indeed, 5-6 hr of insulin treatment produced 80 and 50% decreases in P450 2B and 2E mRNA levels, respectively. Nuclear run-on transcription and mRNA turnover studies were performed to determine the mechanism (transcriptional and/or post-transcriptional) by which insulin modulated these mRNA levels. From our results, it can be concluded that insulin down- regulates the expression of P450 2B by shortening the half-life of its mRNA (half-lives of 6.9 hr without insulin and 3.6 hr with insulin), whereas it down-regulates the expression of P450 2E both by weak repression of the transcription rate (-30%) and, in particular, by acceleration of its mRNA turnover (half-lives of 8.5 hr without insulin and 3.3 hr with insulin).
This article has been cited by other articles:
|
|
 |
|
  A. Hudder and R. F. Novak miRNAs: Effectors of Environmental Influences on Gene Expression and Disease Toxicol. Sci., June 1, 2008; 103(2): 228 - 240. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Ito, K. Asakura, K. Tougou, T. Fukuda, R. Kubota, S. Nonen, Y. Fujio, and J. Azuma Regulation of Cytochrome P450 2E1 under Hypertonic Environment through TonEBP in Human Hepatocytes Mol. Pharmacol., July 1, 2007; 72(1): 173 - 181. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. G. Holloway, E. V. Laz, and D. J. Waxman Codependence of Growth Hormone-Responsive, Sexually Dimorphic Hepatic Gene Expression on Signal Transducer and Activator of Transcription 5b and Hepatic Nuclear Factor 4{alpha} Mol. Endocrinol., March 1, 2006; 20(3): 647 - 660. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Hakkola, Y. Hu, and M. Ingelman-Sundberg Mechanisms of Down-Regulation of CYP2E1 Expression by Inflammatory Cytokines in Rat Hepatoma Cells J. Pharmacol. Exp. Ther., March 1, 2003; 304(3): 1048 - 1054. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Moncion, N. T. Truong, A. Garrone, P. Beaune, R. Barouki, and I. de Waziers Identification of a 16-Nucleotide Sequence That Mediates Post-transcriptional Regulation of Rat CYP2E1 by Insulin J. Biol. Chem., November 22, 2002; 277(48): 45904 - 45910. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Sperker, C. Tomkiewicz, O. Burk, R. Barouki, and H. K. Kroemer Regulation of Human {beta}-Glucuronidase by A23187 and Thapsigargin in the Hepatoma Cell Line HepG2 Mol. Pharmacol., February 1, 2001; 59(2): 177 - 182. [Abstract] [Full Text]
|
|
|
|
 |
|
 A. M. Watson, S. M. Poloyac, G. Howard, and R. A. Blouin Effect of Leptin on Cytochrome P-450, Conjugation, and Antioxidant Enzymes in the ob/ob Mouse Drug Metab. Dispos., June 1, 1999; 27(6): 695 - 700. [Abstract] [Full Text]
|
|
|
|
|
|
A. Simi and M. Ingelman-Sundberg Post-Translational Inhibition of Cytochrome P-450 2E1 Expression by Chlomethiazole in Fao Hepatoma Cells J. Pharmacol. Exp. Ther., May 1, 1999; 289(2): 847 - 852. [Abstract] [Full Text]
|
|
|
|
|
|
H.-M. Peng and M. J. Coon Regulation of Rabbit Cytochrome P450 2E1 Expression in HepG2 Cells by Insulin and Thyroid Hormone Mol. Pharmacol., October 1, 1998; 54(4): 740 - 747. [Abstract] [Full Text]
|
|
|
|
 |
|
 S. Bortoli, M. Amessou, M. Collinet, B. Desbuquois, and S. Lopez Vanadate, But Not Insulin, Inhibits Insulin Receptor Gene Expression in Rat Hepatoma Cells Endocrinology, November 1, 1997; 138(11): 4821 - 4829. [Abstract] [Full Text] [PDF]
|
|
 |
 |
 |
|
 |
 |
 |
